
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Mads Delbo Larsen, Erik L. de Graaf, Myrthe E. Sonneveld, et al.
Science (2020) Vol. 371, Iss. 6532
Open Access | Times Cited: 330
Mads Delbo Larsen, Erik L. de Graaf, Myrthe E. Sonneveld, et al.
Science (2020) Vol. 371, Iss. 6532
Open Access | Times Cited: 330
Showing 26-50 of 330 citing articles:
Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity
Jennifer L. Yates, Dylan Ehrbar, Danielle Hunt, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100329-100329
Open Access | Times Cited: 88
Jennifer L. Yates, Dylan Ehrbar, Danielle Hunt, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100329-100329
Open Access | Times Cited: 88
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 314-338
Open Access | Times Cited: 87
Saborni Chakraborty, Vamsee Mallajosyula, Cristina M. Tato, et al.
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 314-338
Open Access | Times Cited: 87
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
Alexander P. Bye, Willianne Hoepel, Joanne Mitchell, et al.
Blood (2021) Vol. 138, Iss. 16, pp. 1481-1489
Open Access | Times Cited: 85
Alexander P. Bye, Willianne Hoepel, Joanne Mitchell, et al.
Blood (2021) Vol. 138, Iss. 16, pp. 1481-1489
Open Access | Times Cited: 85
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100275-100275
Open Access | Times Cited: 81
Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100275-100275
Open Access | Times Cited: 81
Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
V. Derksen, Theresa Kissel, F. Lamers-Karnebeek, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 8, pp. 1096-1098
Closed Access | Times Cited: 79
V. Derksen, Theresa Kissel, F. Lamers-Karnebeek, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 8, pp. 1096-1098
Closed Access | Times Cited: 79
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 72
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 72
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 72
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 72
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation
Thijs L. J. van Osch, Jan Nouta, Ninotska I. L. Derksen, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 6, pp. 1545-1554
Open Access | Times Cited: 70
Thijs L. J. van Osch, Jan Nouta, Ninotska I. L. Derksen, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 6, pp. 1545-1554
Open Access | Times Cited: 70
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 67
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 67
Glycosylation is a key in SARS-CoV-2 infection
Celso A. Reis, R Tauber, Véronique Blanchard
Journal of Molecular Medicine (2021) Vol. 99, Iss. 8, pp. 1023-1031
Open Access | Times Cited: 66
Celso A. Reis, R Tauber, Véronique Blanchard
Journal of Molecular Medicine (2021) Vol. 99, Iss. 8, pp. 1023-1031
Open Access | Times Cited: 66
Correlates of Vaccine-Induced Protection against SARS-CoV-2
Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 238-238
Open Access | Times Cited: 64
Till Koch, Sibylle C. Mellinghoff, Parichehr Shamsrizi, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 238-238
Open Access | Times Cited: 64
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 63
High-Throughput Glycomic Methods
Irena Trbojević‐Akmačić, Guinevere S. M. Lageveen‐Kammeijer, Bram Heijs, et al.
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15865-15913
Open Access | Times Cited: 62
Irena Trbojević‐Akmačić, Guinevere S. M. Lageveen‐Kammeijer, Bram Heijs, et al.
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15865-15913
Open Access | Times Cited: 62
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Inbal Farkash, Tali Feferman, Noy Cohen Saban, et al.
Cell Reports (2021) Vol. 37, Iss. 11, pp. 110114-110114
Open Access | Times Cited: 61
Inbal Farkash, Tali Feferman, Noy Cohen Saban, et al.
Cell Reports (2021) Vol. 37, Iss. 11, pp. 110114-110114
Open Access | Times Cited: 61
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
Ceri A. Fielding, Pragati Sabberwal, James C. Williamson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 61
Ceri A. Fielding, Pragati Sabberwal, James C. Williamson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 61
Highly active engineered IgG3 antibodies against SARS-CoV-2
Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 59
Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 59
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
Jonathan Douxfils, Julien Favresse, Jean‐Michel Dogné, et al.
Thrombosis Research (2021) Vol. 203, pp. 163-171
Open Access | Times Cited: 58
Jonathan Douxfils, Julien Favresse, Jean‐Michel Dogné, et al.
Thrombosis Research (2021) Vol. 203, pp. 163-171
Open Access | Times Cited: 58
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska I. L. Derksen, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 57
Maurice Steenhuis, Gerard van Mierlo, Ninotska I. L. Derksen, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 5
Open Access | Times Cited: 57
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses
Cillian Gartlan, Tom Tipton, Francisco J. Salguero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Cillian Gartlan, Tom Tipton, Francisco J. Salguero, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Sialylation as an Important Regulator of Antibody Function
Ravi Vattepu, Sunny L. Sneed, Robert M. Anthony
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Ravi Vattepu, Sunny L. Sneed, Robert M. Anthony
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
Tamás Pongrácz, Jan Nouta, Wenjun Wang, et al.
EBioMedicine (2022) Vol. 78, pp. 103957-103957
Open Access | Times Cited: 52
Tamás Pongrácz, Jan Nouta, Wenjun Wang, et al.
EBioMedicine (2022) Vol. 78, pp. 103957-103957
Open Access | Times Cited: 52
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
Josée Golay, Alain E. Andrea, Irene Cattaneo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Josée Golay, Alain E. Andrea, Irene Cattaneo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Glycobiology of rheumatic diseases
Theresa Kissel, René E. M. Toes, T. Huizinga, et al.
Nature Reviews Rheumatology (2022) Vol. 19, Iss. 1, pp. 28-43
Open Access | Times Cited: 48
Theresa Kissel, René E. M. Toes, T. Huizinga, et al.
Nature Reviews Rheumatology (2022) Vol. 19, Iss. 1, pp. 28-43
Open Access | Times Cited: 48